CoChat

Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data

Calabrese, Joseph R, Guelfi, Julien Daniel, Perdrizet‐Chevallier, Catherine, the Agomelatine Bipolar Study Group · 2007 · Bipolar Disorders
Cited by 130

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Objectives: Agomelatine has been shown to be safe and efficient in the treatment of major depressive disorder at 25 mg daily. The aim of this study was to gather preliminary data regarding the antidepressant efficacy of agomelatine in patients with bipolar I disorder experiencing a major depressive episode. Methods: Bipolar I patients on lithium (n = 14) or valpromide (n = 7), with a Hamilton Rating Scale for Depression (HAM‐D‐17) total score ≥ 18, were given adjunctive open‐label agomelatine at 25 mg/day for a minimum of 6 weeks followed by an optional extension of up to an additional 46 weeks. Results: Using intent‐to‐treat data, 81% of patients met criteria for marked improvement (>50% improvement from baseline in HAM‐D score) at study endpoint. Patients were severely depressed at study entry (HAM‐D of 25.2) and 47.6% responded as early as at one week of treatment. Nineteen patients entered the optional extension period for a mean of 211 days (range 6–325 days). Eleven patients completed the one‐year extension on agomelatine. There were no dropouts due to adverse events during the acute phase of treatment (6 weeks). Six patients experienced serious adverse events during the one‐year period. Three lithium‐treated patients experienced manic or hypomanic episodes during the optional extension period, one of which was treatment‐related. Conclusions: These results indicate the effectiveness of agomelatine 25 mg in the treatment of depressed bipolar I patients co‐medicated with lithium or valpromide. A randomized controlled trial is planned to confirm these results.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1399-5618.2007.00507.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 130

Metadata

Authors
Calabrese, J. R., Guelfi, J. D., Perdrizet‐Chevallier, C., & the Agomelatine Bipolar Study Group
Venue
Bipolar Disorders
Publisher
Wiley
Published
2007-09
Volume
9
Issue
6
Pages
628-635
ISSN
  • 1398-5647 (ISSN-L)
  • 1399-5618
OpenAlex
W2031809759
Cited by
130
References
3
FWCI
5.10
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data. https://app.cochat.ai/papers/10.1111/j.1399-5618.2007.00507.x
The paper
Calabrese, J. R., Guelfi, J. D., Perdrizet‐Chevallier, C., & the Agomelatine Bipolar Study Group. (2007). Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data. Bipolar Disorders. https://doi.org/10.1111/j.1399-5618.2007.00507.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.